Provectus Biopharmaceuticals, Inc. filed its 10-K on Mar 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1902 USD | -2.14% | -2.91% | +98.12% |
1st Jan change | Capi. | |
---|---|---|
+98.12% | 81.51M | |
+7.70% | 113B | |
+11.06% | 106B | |
+0.41% | 22.27B | |
-11.95% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.74% | 17.24B | |
+6.89% | 14.29B | |
+35.85% | 12.52B |
- Stock Market
- Equities
- PVCT Stock
- News Provectus Biopharmaceuticals, Inc.
- Provectus Biopharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt